Group 1: Snowflake Inc - Snowflake Inc reported third-quarter revenue of $1.21 billion, exceeding analyst estimates of $1.18 billion [1] - The company achieved adjusted earnings of 35 cents per share, surpassing analyst expectations of 31 cents per share [1] - In pre-market trading, Snowflake shares fell 8.6% to $241.85 following the earnings report [2] Group 2: Other Companies - Net Lease Office Properties saw a decline of 14.7%, with shares dropping to $25.19 in pre-market trading [4] - Symbotic Inc shares fell 10.5% to $65.50 after announcing a 10 million share offering [4] - Capricor Therapeutics Inc experienced an 8.4% dip to $27.45 after a significant increase of 371% the previous day [4] - ADC Therapeutics SA shares declined 8.1% to $3.63 following updated trial data [4] - Koninklijke Philips NV shares fell 6.8% to $26.11 in pre-market trading [4] - Omeros Corp declined 4.2% to $10.18, while Methanex Corp fell 3.8% to $35.95 [4]

Group 1: Snowflake Inc (NYSE:SNOW) - Snowflake reported third-quarter revenue of $1.21 billion, exceeding analyst estimates of $1.18 billion [1] - The company achieved adjusted earnings of 35 cents per share, surpassing analyst expectations of 31 cents per share [1] - In pre-market trading, Snowflake shares fell 8.6% to $241.85 [2] Group 2: Other Companies - Net Lease Office Properties (NYSE:NLOP) shares decreased by 14.7% to $25.19 in pre-market trading [4] - Symbotic Inc (NASDAQ:SYM) shares dropped 10.5% to $65.50 following a 10 million share offering announcement [4] - Capricor Therapeutics Inc (NASDAQ:CAPR) shares fell 8.4% to $27.45 after a significant increase of 371% the previous day [4] - ADC Therapeutics SA (NYSE:ADCT) shares declined 8.1% to $3.63 after reporting updated data from its LOTIS-7 trial [4] - Koninklijke Philips NV (NYSE:PHG) shares decreased by 6.8% to $26.11 in pre-market trading [4] - Omeros Corp (NASDAQ:OMER) shares fell 4.2% to $10.18 [4] - Methanex Corp (NASDAQ:MEOH) shares dropped 3.8% to $35.95 [4]

Market Overview - U.S. stocks experienced an upward trend, with the Dow Jones increasing by over 250 points, closing up 0.61% at 47,765.87, while the NASDAQ rose 0.07% to 23,430.56, and the S&P 500 gained 0.22% to 6,844.57 [1] - Energy shares saw a notable increase of 1.2%, while information technology stocks fell by 0.6% [1] Company Performance - Macy's Inc reported third-quarter sales of $4.713 billion, a decrease of 0.6% year-over-year, but exceeded analysts' expectations of $4.621 billion. The company also reported adjusted earnings per share of 9 cents [2] Commodity Market - Oil prices rose by 1% to $59.21, gold increased by 0.6% to $4,246.90, silver was up 0.4% to $58.935, and copper saw a significant rise of 3% to $5.4000 [5] European Market - European shares were mostly higher, with the eurozone's STOXX 600 rising by 0.16%, Spain's IBEX 35 Index increasing by 1.55%, while London's FTSE 100 fell slightly by 0.02% [6] Asian Market - Asian markets closed mixed, with Japan's Nikkei gaining 1.14%, while Hong Kong's Hang Seng fell by 1.28%, China's Shanghai Composite decreased by 0.51%, and India's BSE Sensex fell by 0.04% [7] Notable Stock Movements - Capricor Therapeutics, Inc. saw a dramatic increase of 291% to $24.87 following positive trial results for its cell therapy [8] - Virax Biolabs Group Limited surged 71% to $0.6709 after announcing clinical progress [8] - Aeva Technologies, Inc. gained 16% to $12.58 after being selected as a LiDAR supplier for a major European OEM [8] - CIMG Inc. shares dropped 35% to $0.1200 due to a reverse stock split announcement [8] - ADC Therapeutics SA fell 29% to $3.2499 after reporting updated trial data [8] - Pure Storage, Inc. decreased by 26% to $69.99 following its third-quarter results [8] Economic Indicators - The S&P Global services PMI declined to 54.1 in November from 54.8, and the composite PMI fell to 54.2 from 54.6 [11] - U.S. industrial production increased by 0.1% month-over-month in September, contrasting with a revised 0.3% decline in August [11] - Private businesses in the U.S. reduced jobs by 32,000 in November, compared to a revised gain of 47,000 in the previous month [11] - U.S. crude oil inventories rose by 0.574 million barrels in the week ending Nov. 28, compared to a 2.774 million barrel gain in the previous week [11]

Market Overview - U.S. stocks experienced an upward trend, with the Dow Jones increasing by over 250 points, closing at 47,765.87, a rise of 0.61% [1] - The NASDAQ rose by 0.07% to 23,430.56, while the S&P 500 gained 0.22% to reach 6,844.57 [1] - Energy shares saw a notable increase of 1.2%, while information technology stocks fell by 0.6% [1] Company Performance - Macy's Inc reported third-quarter sales of $4.713 billion, a decrease of 0.6% year-over-year, but exceeded analysts' expectations of $4.621 billion. The adjusted earnings per share for the quarter were 9 cents [2] Commodity Market - Oil prices rose by 1% to $59.21, while gold increased by 0.6% to $4,246.90. Silver and copper also saw gains of 0.4% to $58.935 and 3% to $5.4000, respectively [5] European Market - European shares were mostly higher, with the eurozone's STOXX 600 rising by 0.16% and Spain's IBEX 35 Index increasing by 1.55%. However, London's FTSE 100 fell slightly by 0.02% [6] Asian Market - Asian markets closed mixed, with Japan's Nikkei gaining 1.14%, while Hong Kong's Hang Seng, China's Shanghai Composite, and India's BSE Sensex experienced declines of 1.28%, 0.51%, and 0.04%, respectively [7] Notable Stock Movements - Capricor Therapeutics, Inc. shares surged by 291% to $24.87 following positive results from its Phase 3 HOPE-3 Trial [8] - Virax Biolabs Group Limited shares increased by 71% to $0.6709 due to clinical progress announcements [8] - Aeva Technologies, Inc. saw a 16% rise to $12.58 after being selected as a LiDAR supplier for a major European OEM [8] - CIMG Inc. shares dropped by 35% to $0.1200 after announcing a reverse stock split [8] - ADC Therapeutics SA shares fell by 29% to $3.2499 following updated trial data [8] - Pure Storage, Inc. shares decreased by 26% to $69.99 after reporting third-quarter results [8] Economic Indicators - The S&P Global services PMI declined to 54.1 in November from 54.8 in the previous month [11] - U.S. industrial production increased by 0.1% month-over-month in September, contrasting with a revised 0.3% decline in August [11] - Private businesses in the U.S. reduced jobs by 32,000 in November, compared to a revised gain of 47,000 in the previous month [11] - U.S. crude oil inventories rose by 0.574 million barrels in the week ending Nov. 28, compared to a 2.774 million barrel gain in the previous week [11]

Market Overview - U.S. stocks showed mixed performance with the Dow Jones increasing by 0.16% to 47,548.62, while the NASDAQ decreased by 0.42% to 23,316.49 and the S&P 500 fell by 0.07% to 6,824.67 [1] Company Performance - Dollar Tree, Inc. reported third-quarter adjusted earnings per share of $1.21, surpassing the analyst consensus estimate of $1.08. The company achieved quarterly sales of $4.746 billion, reflecting a year-over-year growth of 9.4%, exceeding the expected sales of $4.699 billion [2] Commodity Market - In commodity trading, oil prices rose by 0.9% to $59.18, gold increased by 0.9% to $4,256.90, silver went up by 0.4% to $58.930, and copper saw a significant rise of 2.8% to $5.3865 [5] European Market - European shares generally experienced gains, with the eurozone's STOXX 600 increasing by 0.2%, Spain's IBEX 35 Index rising by 1.6%, and other major indices like London's FTSE 100, Germany's DAX 40, and France's CAC 40 all showing slight increases of 0.1% [6] Asian Market - Asian markets closed mixed, with Japan's Nikkei gaining 1.14%, while Hong Kong's Hang Seng fell by 1.28%, China's Shanghai Composite decreased by 0.51%, and India's BSE Sensex saw a minor decline of 0.04% [7] Notable Stock Movements - Capricor Therapeutics, Inc. shares surged by 441% to $34.40 following positive results from its Phase 3 HOPE-3 Trial for Duchenne Muscular Dystrophy. Virax Biolabs Group Limited shares increased by 66% to $0.6511 due to clinical progress announcements [9] - Conversely, CIMG Inc. shares dropped by 35% to $0.1201 after announcing a 20-for-1 reverse stock split, and Black Diamond Therapeutics, Inc. shares fell by 28% to $2.4800 after reporting preliminary Phase 2 data [9]